Partnership and collaboration
License contract / capital alliance
Sumitomo Chemical Company, Limited
License contract and capital alliance for the manufacture and distribution of nucleic acid drug substance
Toray Industries
License contract and capital alliance for BNC-1021/TRK-250 with idiopathic pulmonary fibrosis as the target disorder
FUJIFILM Corporation
Collaborative research and capital alliance for the liposomal formulation of nucleic acid drugs
Collaboration Research
Fukuoka Prefecture
Strategic collaboration to accelerate COVID-19 treatment drug development
Industry-academia collaborative laboratory
Donated Fund Laboratory of Advanced Medicine, Department of Molecular Pathology, Tokyo Medical University (head of laboratory: Professor Masahiko Kuroda)
Promoting drug discovery of nucleic acid medicine using the fundamental technology of RNA
Community collaborative donated fund laboratory
Department of Inflammology, Research Center for Advanced Science and Technology, The University of Tokyo (Project Associate Professor Hideyuki Yanai)
Promoting the research of molecular mechanisms relating to inflammatory and immune disorders
Comprehensive research collaboration
Kurume University (observer: Kurume City)
Comprehensive collaboration and cooperation in the area of research and development for next-generation drug discovery, thereby contributing to the advancement of medicine and medical care as well as the development of the industry and community.
